Sun Pharmaceutical Industries' Q3 net profit falls nearly 5% to Rs 1,471.82 crore

Highlights:

1.The company's consolidated net profit for the October to December quarter of FY17 fell by 4.73% to Rs 1,471.82 crore as against Rs 1,544.85 crore in the October to December quarter of FY16

2.Its total income from operations during the period under review rose by 11.01% to Rs 7,912.66 crore as compared to Rs 7,122.31 crore in the year-ago period

3.The company's total comprehensive income during the quarter declined by 19.28% to Rs 1,802.73 crore as compared to Rs 2,233.39 crore in the similar quarter of last fiscal

Sun Pharmaceutical Industries on Tuesday reported nearly 5% fall in the consolidated net profit for the third quarter (Q3) of the fiscal year 2016-17 (FY17) ended on December 31 last year.

"The company's net profit for the October to December quarter of FY17 fell by 4.73% to Rs 1,471.82 crore as against Rs 1,544.85 crore in the October to December quarter of FY16," cited Sun Pharmaceutical Industries in a filing to the BSE. 

Its total income from operations during the period under review rose by 11.01% to Rs 7,912.66 crore as compared to Rs 7,122.31 crore in the year-ago period, the company said.

The company's total comprehensive income during the quarter declined by 19.28% to Rs 1,802.73 crore as compared to Rs 2,233.39 crore in the similar quarter of last fiscal.

The pharma company's total expenses during the quarter increased by 12.46% to Rs 5,766.33 crore as against Rs 5,127.55 crore in the corresponding period of previous fiscal.

See LIVE stock updates of Sun Pharmaceutical Industries here-

On Tuesday, the stock of Sun Pharmaceutical Industries closed down 0.73% or Rs 4.80 at Rs 650.15 on the BSE.